Brigatinib Clinical Trials

4 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: ALUNBRIG, Alunbrig, Alunbrig Tablets

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

Takeda1
Scott R. Plotkin, MD, PhD1
Princess Maxima Center for Pediatric Oncology1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Indications

Cancer4
Lung Cancer2
Non-vestibular Schwannoma1
Neurofibromatosis Type 21
Sex Disorder1

Other3 trials

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors

Phase 1/2

ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer

Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

Los Angeles, California1 trial

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

UCLA Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.